A study of conformational restraints on reactivity of human PR3-specific autoantibodies (ANCA) facilitated through protein folding manipulations of a new recombinant proteinase 3 protein

References

• Jenne DE, Tschopp J, Ludemann J, Utecht B, Gross WL. Wegener's autoantigen decoded (letter). Nature 1990; 346: 520
   PubMed Web of Science ®Google Scholar
• Fujinaga M, Chernaia MM, Halenbeck R, Koths K, James MN. The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies. J Mol Biol 1996; 261: 267–278
   PubMed Web of Science ®Google Scholar
• Rao NV, Rao GV, Marshall BC, Hoidal JR. Biosynthesis and processing of proteinase 3 in U937 cells. J Biol Chem 1996; 271(2972)2978
   Google Scholar
• Russell KA, Fass DN, Specks U. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis. Arthritis Rheum 2001; 44(463)468
   Google Scholar
• Rao NV, Wehner NG, Marshall BC, Gray WR, Gray BH, Hoidal JR. Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J Biol Chem 1991; 266(9540)9548
   Google Scholar
• Specks U. What you should know about PR3-ANCA. Conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition by PR3-ANCA. Arthritis Res 2000; 2: 263–267
   PubMedGoogle Scholar
• Bini P, Gabay JE, Teitel A, Melchior M, Zhou JL, Elkon KB. Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3. J Immunol 1992; 149: 1409–1415
   PubMed Web of Science ®Google Scholar
• Hellmark T, Burkhardt H, Wieslander J. Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies. J Biol Chem 1999; 274: 25862–25868
   PubMed Web of Science ®Google Scholar
• Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59–74
   PubMed Web of Science ®Google Scholar
• Loo TW, Clarke DM. Rapid purification of human P-glycoprotein mutants expressed transiently in HEK 293 cells by nickel-chelate chromatography and characterization of their drug-stimulated ATPase activities. J Biol Chem 1995; 270: 21449–21452
   PubMed Web of Science ®Google Scholar
• Manna PR, Joshi L, Reinhold VN, Aubert ML, Suganuma N, Pettersson K, Huhtaniemi IT. Synthesis, purification and structural and functional characterization of recombinant form of a common genetic variant of human luteinizing hormone. Hum Mol Genet 2002; 11: 301–315
   PubMed Web of Science ®Google Scholar
• van der Geld YM, Tool AT, Videler J, de Haas M, Tervaert JW, Stegeman CA, Limburg PC, Kallenberg CG, Roos D. Interference of PR3-ANCA with the enzymatic activity of PR3: Differences in patients during active disease or remission of Wegener's granulomatosis. Clin Exp Immunol 2002; 129: 562–570
   PubMed Web of Science ®Google Scholar
• Preston GA, Zarella CS, Pendergraft WF, 3rd, Rudolph EH, Yang JJ, Sekura SB, Jennette JC, Falk RJ. Novel effects of neutrophil-derived proteinase 3 and elastase on the vascular endothelium involve in vivo cleavage of NF-kappaB and proapoptotic changes in JNK, ERK, and p38 MAPK signaling pathways. J Am Soc Nephrol 2002; 13: 2840–2849
   PubMed Web of Science ®Google Scholar
• Sun J, Fass DN, Viss MA, Hummel AM, Tang H, Homburger HA, Specks U. A proportion of proteinase 3 (PR3)-specific anti-neutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptide. Clin Exp Immunol 1998; 114: 320–326
   PubMed Web of Science ®Google Scholar
• Szymkowiak CH, Johnston TW, Csernok E, Gross WL. Expression of the human autoantigen of Wegener's granulomatosis (PR3) in a baculovirus expression system. Biochem Biophys Res Commun 1996; 219: 283–289
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Halbwachs-Mecarelli L, Almeida RP, Nusbaum P, Melchior M, Jamaleddine G, Lesavre P, Descamps-Latscha B, Gabay JE. Characterization of a recombinant proteinase 3, the autoantigen in Wegener's granulomatosis and its reactivity with anti-neutrophil cytoplasmic autoantibodies. FEBS Lett 1996; 382: 130–136
   PubMed Web of Science ®Google Scholar
• Harmsen MC, Heeringa P, van der Geld YM, Huitema MG, Klimp A, Tiran A, Kallenberg CG. Recombinant proteinase 3 (Wegener's antigen) expressed in Pichia pastoris is functionally active and is recognized by patient sera. Clin Exp Immunol 1997; 110: 257–264
   PubMed Web of Science ®Google Scholar
• van der Geld YM, Oost-Kort W, Limburg PC, Specks U, Kallenberg CG. Recombinant proteinase 3 produced in different expression systems: Recognition by anti-PR3 antibodies. J Immunol Methods 2000; 244: 117–131
   PubMed Web of Science ®Google Scholar
• Rarok AA, Huitema MG, van der Leij MJ, van der Geld YM, Berthold H, Schmitt J, Stegeman CA, Limburg PC, Kallenberg CG. Recombinant protein to analyze autoantibodies to proteinase 3 in systemic vasculitis. Am J Clin Pathol 2003; 120: 586–595
   PubMed Web of Science ®Google Scholar
• Fonda I, Kenig M, Gaberc-Porekar V, Pristovaek P, Menart V. Attachment of histidine tags to recombinant tumor necrosis factor-alpha drastically changes its properties. ScientificWorldJournal 2002; 2: 1312–1325
   PubMedGoogle Scholar
• Specks U, Wiegert EM, Homburger HA. Human mast cells expressing recombinant proteinase 3 (PR3) as substrate for clinical testing for anti-neutrophil cytoplasmic antibodies (ANCA). Clin Exp Immunol 1997; 109: 286–295
   PubMed Web of Science ®Google Scholar
• Specks U, Fass DN, Fautsch MP, Hummel AM, Viss MA. Recombinant human proteinase 3, the Wegener's autoantigen, expressed in HMC-1 cells is enzymatically active and recognized by c-ANCA. FEBS Lett 1996; 390: 265–270
   PubMed Web of Science ®Google Scholar
• Sun J, Fass DN, Hudson JA, Viss MA, Wieslander J, Homburger HA, Specks U. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes. J Immunol Methods 1998; 211: 111–123
   PubMed Web of Science ®Google Scholar
• Capizzi SA, Viss MA, Hummel AM, Fass DN, Specks U. Effects of carboxy-terminal modifications of proteinase 3 (PR3) on the recognition by PR3-ANCA. Kidney Int 2003; 63: 756–760
   PubMed Web of Science ®Google Scholar
• Selga D, Segelmark M, Wieslander J, Gunnarsson L, Hellmark T. Epitope mapping of anti-PR3 antibodies using chimeric human/mouse PR3 recombinant proteins. Clin Exp Immunol 2004; 135: 164–172
   PubMed Web of Science ®Google Scholar
• Hellmark T, Segelmark M, Wieslander J. Anti-GBM antibodies in Goodpasture syndrome; anatomy of an epitope. Nephrol Dial Transplant 1997; 12: 646–648
   PubMed Web of Science ®Google Scholar
• Hellmark T, Segelmark M, Unger C, Burkhardt H, Saus J, Wieslander J. Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease. Kidney Int 1999; 55: 936–944
   PubMed Web of Science ®Google Scholar
• Gunnarsson A, Hellmark T, Wieslander J. Molecular properties of the Goodpasture epitope. J Biol Chem 2000; 275: 30844–30848
   PubMed Web of Science ®Google Scholar
• Westman KW, Selga D, Bygren P, Segelmark M, Baslund B, Wiik A, Wieslander J. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody. Kidney Int 1998; 53: 1230–1236
   PubMed Web of Science ®Google Scholar
• Yang JJ, Preston GA, Pendergraft WF, Segelmark M, Heeringa P, Hogan SL, Jennette JC, Falk RJ. Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. Am J Pathol 2001; 158: 581–592
   PubMed Web of Science ®Google Scholar
• Pendergraft WF, 3rd, Preston GA, Shah RR, Tropsha A, Carter CW, Jr., Jennette JC, Falk RJ. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004; 10: 72–79
   PubMed Web of Science ®Google Scholar